 --Company to Host Conference Call November 14, 2022, at 8:00AM ET--- RADNOR, Pa. , Nov. 10, 2022 PRNewswire -- NRx Pharmaceuticals, Inc. Nasdaq: NRXP NRx Pharmaceuticals, the Company, a clinical-stage, biopharmaceutical company today announced that management will report third quarter 2022 financial results prior to the market open on November 14, 2022. 